TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis
- 30 June 2011
- journal article
- research article
- Published by Elsevier BV in Cancer Cell
- Vol. 20 (1), 25-38
- https://doi.org/10.1016/j.ccr.2011.06.003
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Tet1 and Tet2 Regulate 5-Hydroxymethylcytosine Production and Cell Lineage Specification in Mouse Embryonic Stem CellsCell Stem Cell, 2011
- DNMT3AMutations in Acute Myeloid LeukemiaThe New England Journal of Medicine, 2010
- Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2Nature, 2010
- Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specificationNature, 2010
- Genetic Analysis of Transforming Events That Convert Chronic Myeloproliferative Neoplasms to LeukemiasCancer Research, 2010
- Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignanciesBlood, 2009
- Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasmsBlood, 2009
- Mutation in TET2 in Myeloid CancersThe New England Journal of Medicine, 2009
- Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1Science, 2009
- The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the BrainScience, 2009